ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SYN Synthetic Biologics Inc

1.02
0.00 (0.00%)
10 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Synthetic Biologics Inc AMEX:SYN AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.02 0 00:00:00

Trading Update

31/03/2003 8:00am

UK Regulatory


RNS Number:3830J
Synstar PLC
31 March 2003

31 March 2003



                                  Synstar Plc

                                  ("Synstar")



Ahead of entering its close period, Synstar, the pan-European IT services
provider, is today updating the market on trading for the six month period ended
31 March 2003.


We are pleased to confirm that current trading continues in line with market
expectations.  We continue to make progress cross-selling our services into
current customers with recent examples at Avecia, London Electricity and First
Group.   Additionally our efforts in new name sales have been rewarded with new
contract wins including Cognotec and Atomic Weapons Establishment.  Our plans
for the recovery of our French business remain on track and feature the signing
of several multi-service line deals, for example, with CORSAIR.


Our order book remains strong, benefiting from regularly winning larger, more '
joined up' deals.  We continue to adjust our mix of services, exiting
under-performing contracts in order to maintain upward pressure on overall
margins.


The Board remains confident that Synstar's flexible and innovative approach to
its customers' end to end IT requirements, coupled with continuing excellent
customer satisfaction results, means the Group is well placed to deliver
enhanced profitability going forward.


Synstar will be announcing its interim results for the six months ended 31 March
2003 on Friday 30 May 2003.



For further information please contact:

Steve Vaughan/Stephen Gleadle
Synstar Plc                                                  Tel: 01344 662700


Edward Bridges / James Melville-Ross / Juliet Clarke
Financial Dynamics                                           Tel: 020 7831 3113






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

TSTDVLFLXXBBBBZ

1 Year Synthetic Biologics Chart

1 Year Synthetic Biologics Chart

1 Month Synthetic Biologics Chart

1 Month Synthetic Biologics Chart

Your Recent History

Delayed Upgrade Clock